Latest filing published 18 Dec 2025 for ELUTIA INC., €11k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brigid Makes, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Definium Therapeutics, Inc., Vivani Medical, Inc. and Elutia Inc. Over a trading history stretching from 11 June 2021 to 17 December 2025, the count stands at 9 filings.
Purchases make up the whole of the open-market record (5 purchases, €24k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants. In 2025 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €3,238. Clusters matter here: 5 out of 5 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 18 December 2025 came the latest disclosure, an open-market purchase for €11k in Elutia Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations